Financial Review: Amalgamated Financial (NASDAQ:AMAL) and Advanced Medical Isotope (OTCMKTS:RDGL)

Advanced Medical Isotope (OTCMKTS:RDGL) and Amalgamated Financial (NASDAQ:AMAL) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Insider and Institutional Ownership

75.9% of Amalgamated Financial shares are held by institutional investors. 18.5% of Advanced Medical Isotope shares are held by insiders. Comparatively, 1.3% of Amalgamated Financial shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for Advanced Medical Isotope and Amalgamated Financial, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Isotope	0	0	0	0	0.00
Amalgamated Financial	0	2	1	0	2.33

Amalgamated Financial has a consensus target price of $33.50, suggesting a potential upside of 4.02%. Given Amalgamated Financial’s stronger consensus rating and higher possible upside, analysts clearly believe Amalgamated Financial is more favorable than Advanced Medical Isotope.

Profitability

This table compares Advanced Medical Isotope and Amalgamated Financial’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Advanced Medical Isotope	-6,144.90%	N/A	-113.56%
Amalgamated Financial	22.97%	14.75%	1.30%

Volatility & Risk

Advanced Medical Isotope has a beta of -0.5, suggesting that its stock price is 150% less volatile than the S&P 500. Comparatively, Amalgamated Financial has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500.

Valuation & Earnings

This table compares Advanced Medical Isotope and Amalgamated Financial”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Isotope	$30,000.00	1,045.37	-$2.91 million	N/A	N/A
Amalgamated Financial	$434.51 million	2.22	$106.43 million	$3.32	9.70

Amalgamated Financial has higher revenue and earnings than Advanced Medical Isotope.

Summary

Amalgamated Financial beats Advanced Medical Isotope on 10 of the 12 factors compared between the two stocks.

About Advanced Medical Isotope

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

About Amalgamated Financial

Amalgamated Financial Corp. operates as the bank holding company for Amalgamated Bank that provides commercial and retail banking, investment management, and trust and custody services for commercial and retail customers in the United States. The company accepts various deposit products, including non-interest bearing accounts, interest-bearing demand products, savings accounts, money market accounts, NOW accounts, and certificates of deposit. It also provides various commercial loans comprising commercial and industrial, multifamily mortgage, and commercial real estate loans; residential mortgage loans; and retail loans, such as residential real estate, consumer solar, and consumer and other loans. In addition, the company offers online banking, bill payment, online cash management, and safe deposit box rental services; debit and ATM cards; and trust, custody, and investment management services comprising asset safekeeping, corporate actions, income collections, proxy, account transition, asset transfers, and conversion management services. Further, it provides investment products, such as funds spanning equity, fixed-income, real estate, and alternative investment products; and brokerage, asset management, and insurance products. Amalgamated Financial Corp. was founded in 1923 and is headquartered in New York, New York.